Koshinski Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Koshinski Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12	Closed	-$1.08K	–	1981
2022 Q1	$1.08K	Hold	12	–	–	﹤0.01%	2054
2021 Q4	$1.34K	Hold	12	–	–	﹤0.01%	2050
2021 Q3	$1.51K	Buy	+12	New	+$1.54K	﹤0.01%	2070
2021 Q1	–	Sell	-6,417	Closed	-$903K	–	644
2020 Q4	$903K	Sell	6,417 -71	-1%	-$9.09K	0.11%	207
2020 Q3	$782	Buy	6,488 +364	+6%	+$40.8K	0.11%	214
2020 Q2	$686K	Buy	+6,124	New	+$603K	0.11%	217

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Koshinski Asset Management's XBI Position: Q2 2022 in Review

Koshinski Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 12 shares — an estimated $1.08K sold.

Koshinski Asset Management first reported a position in XBI in Q2 2020 and held it in 6 quarters. The position peaked at $903K in Q4 2020. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Koshinski Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Koshinski Asset Management sold 12 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $1.08K.
Koshinski Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 6 quarters.
Koshinski Asset Management's State Street SPDR S&P Biotech ETF position peaked at $903K in Q4 2020.
706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.